Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

China Reform Health Management and Services Group Co., Ltd. (000503.SZ)

Compare
10.39
+0.01
+(0.10%)
At close: April 11 at 3:04:42 PM GMT+8
Loading Chart for 000503.SZ
  • Previous Close 10.38
  • Open 10.57
  • Bid 10.39 x --
  • Ask 10.40 x --
  • Day's Range 10.21 - 10.62
  • 52 Week Range 6.24 - 17.35
  • Volume 23,274,116
  • Avg. Volume 41,209,986
  • Market Cap (intraday) 10.196B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM)
  • EPS (TTM) 0.00
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 31, 2004
  • 1y Target Est --

China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. The company is involved in business that covers 177 medical insurance in 25 provinces. It is also involved in the pharmaceutical and medical business. The company was formerly known as SeaRainbow Holding Corp. and changed its name to China Reform Health Management and Services Group Co., Ltd. in May 2018. China Reform Health Management and Services Group Co., Ltd. was founded in 1987 and is based in Beijing, China.

www.crhms.cn

1,420

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 000503.SZ

View More

Performance Overview: 000503.SZ

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000503.SZ
5.37%
SSE Composite Index (000001.SS)
3.39%

1-Year Return

000503.SZ
14.05%
SSE Composite Index (000001.SS)
6.72%

3-Year Return

000503.SZ
6.78%
SSE Composite Index (000001.SS)
2.24%

5-Year Return

000503.SZ
21.76%
SSE Composite Index (000001.SS)
15.79%

Compare To: 000503.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 000503.SZ

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    10.20B

  • Enterprise Value

    9.15B

  • Trailing P/E

    6.49k

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    27.32

  • Price/Book (mrq)

    7.34

  • Enterprise Value/Revenue

    24.76

  • Enterprise Value/EBITDA

    1.96k

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.59%

  • Return on Assets (ttm)

    -4.99%

  • Return on Equity (ttm)

    -0.38%

  • Revenue (ttm)

    369.39M

  • Net Income Avi to Common (ttm)

    -2.19M

  • Diluted EPS (ttm)

    0.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.24B

  • Total Debt/Equity (mrq)

    13.59%

  • Levered Free Cash Flow (ttm)

    -128.69M

Research Analysis: 000503.SZ

View More

Company Insights: 000503.SZ

Research Reports: 000503.SZ

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.